Alpha Tau Medical (DRTS) Income from Continuing Operations (2021 - 2026)

Alpha Tau Medical's (DRTS) quarterly Income from Continuing Operations came in at 22950000.0 in Q1 2026, up 170.22% year-on-year from 8493000.0 in Q1 2025, and up 88.02% quarter-over-quarter from 12206000.0 in Q4 2025.

Alpha Tau Medical (DRTS) Income from Continuing Operations (2021 - 2026) Analysis & Trends

Alpha Tau Medical has disclosed Income from Continuing Operations across 6 years of filings, most recently posting 22950000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 22950000.0, up 170.22% year-over-year; the trailing twelve-month figure through Mar 2026 was 56842000.0 (up 76.24% YoY), and the FY2025 annual result was 42385000.0, up 33.55% from the prior year.
  • Income from Continuing Operations came in at 22950000.0 for Q1 2026 at Alpha Tau Medical, up from 12206000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 25740000.0 in Q1 2022 to a low of 1987000.0 in Q2 2022.
  • The 5-year median for Income from Continuing Operations is 8145000.0 (2023), against an average of 9407058.82.
  • Across the five-year window, Income from Continuing Operations sank 71.42% in 2022 and jumped 334.88% in 2023, its largest moves.
  • Alpha Tau Medical's Income from Continuing Operations stood at 3390000.0 in 2022, then jumped by 116.78% to 7349000.0 in 2023, then rose by 28.89% to 9472000.0 in 2024, then rose by 28.86% to 12206000.0 in 2025, then jumped by 88.02% to 22950000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 22950000.0 (Q1 2026), 12206000.0 (Q4 2025), and 11702000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -2.97 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -14.46 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -3.40 Mn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 1.03 Bn
9 Abivax 95.45 Bn 95.45 Bn - -56.48 Mn
10 Alpha Tau Medical 2,384.20 -76.42 Mn - 22.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.95 Mn
Dec 31, 2025 12.21 Mn
Sep 30, 2025 11.70 Mn
Jun 30, 2025 9.98 Mn
Mar 31, 2025 8.49 Mn
Dec 31, 2024 9.47 Mn
Sep 30, 2024 6.92 Mn
Jun 30, 2024 7.36 Mn
Mar 31, 2024 7.98 Mn
Dec 31, 2023 7.35 Mn
Sep 30, 2023 4.99 Mn
Jun 30, 2023 8.64 Mn
Mar 31, 2023 8.15 Mn
Dec 31, 2022 3.39 Mn
Sep 30, 2022 2.61 Mn
Jun 30, 2022 1.99 Mn
Mar 31, 2022 25.74 Mn
Dec 31, 2021 3.81 Mn
Sep 30, 2021 4.81 Mn
Jun 30, 2021 6.95 Mn